DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR VEPESID
Clinical Trials for Vepesid
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00002835 | Combination Chemotherapy in Treating Patients With Lymphoma | Completed | National Cancer Institute (NCI) | Phase 3 | 1995-07-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. PURPOSE: Randomized phase III trial to compare the effectiveness of two regimens of combination chemotherapy in treating patients who have intermediate-grade or immunoblastic lymphoma. |
| NCT00002835 | Combination Chemotherapy in Treating Patients With Lymphoma | Completed | M.D. Anderson Cancer Center | Phase 3 | 1995-07-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. PURPOSE: Randomized phase III trial to compare the effectiveness of two regimens of combination chemotherapy in treating patients who have intermediate-grade or immunoblastic lymphoma. |
| NCT00006047 | Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide | Completed | Astex Pharmaceuticals | Phase 1 | 2000-06-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of nitrocamptothecin plus etoposide in treating patients who have advanced solid tumors. |
| NCT00006047 | Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide | Completed | National Cancer Institute (NCI) | Phase 1 | 2000-06-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of nitrocamptothecin plus etoposide in treating patients who have advanced solid tumors. |
| NCT00006047 | Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide | Completed | H. Lee Moffitt Cancer Center and Research Institute | Phase 1 | 2000-06-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of nitrocamptothecin plus etoposide in treating patients who have advanced solid tumors. |
| NCT00006373 | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma | Completed | National Cancer Institute (NCI) | Phase 2 | 2000-02-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell or bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy followed by autologous bone marrow transplantation or peripheral stem cell transplantation in treating patients who have non-Hodgkin's lymphoma or Hodgkin's lymphoma. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Vepesid
Clinical Trial Locations for Vepesid
Trials by Country
Clinical Trial Progress for Vepesid
Clinical Trial Phase
Clinical Trial Status
Clinical Trial Sponsors for Vepesid
Sponsor Name
